MARKET

MSON

MSON

Misonix
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.39
+0.14
+0.77%
Opening 09:42 05/06 EDT
OPEN
18.39
PREV CLOSE
18.25
HIGH
18.39
LOW
18.39
VOLUME
155
TURNOVER
--
52 WEEK HIGH
20.71
52 WEEK LOW
9.06
MARKET CAP
319.83M
P/E (TTM)
-15.3698
1D
5D
1M
3M
1Y
5Y
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5)
Benzinga · 1h ago
Earnings Scheduled For May 6, 2021
  Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
Benzinga · 5h ago
Canaccord Genuity Sticks to Their Buy Rating for Misonix (MSON)
In a report issued on May 2, Kyle Rose from Canaccord Genuity maintained a Buy rating on Misonix (MSON), with a price target of $20.00. The company's
SmarterAnalyst · 21h ago
Earnings Outlook For Misonix
On Thursday, May 06, Misonix (NASDAQ:MSON) will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Benzinga · 23h ago
Ultrasonic Scalpels Market Size Research Report 2021: Growth Strategies by Top Players, Global Business Share and Trends with Impact of Covid-19, Forthcoming Development Status Forecast to 2027
May 04, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Ultrasonic Scalpels Market” report...
The Express Wire · 2d ago
Tumor Ablation Market 2021 Industry Growth Insights, Size, Share, Demand, Technology Progress, Industry News Update Research Report Forecast to 2025
May 04, 2021 (The Expresswire) -- “Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Tumor Ablation Market” report...
The Express Wire · 2d ago
Radioactive Iodine Ablation Therapy Market Trends, Key Players, Overview, Competitive Breakdown and Regional Forecast by 2028 | FMI Report with Expert Review
May 04, 2021 (MARKITWIRED via COMTEX) -- Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and...
Markitwired · 2d ago
Did You Miss Misonix's (NASDAQ:MSON) Impressive 264% Share Price Gain?
Simply Wall St. · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MSON. Analyze the recent business situations of Misonix through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MSON stock price target is 22.00 with a high estimate of 23.00 and a low estimate of 20.00.
EPS
Institutional Holdings
Institutions: 89
Institutional Holdings: 7.62M
% Owned: 43.80%
Shares Outstanding: 17.39M
TypeInstitutionsShares
Increased
20
185.49K
New
4
132.65K
Decreased
18
170.73K
Sold Out
5
332.38K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.17%
Healthcare Equipment & Supplies
-1.03%
Key Executives
Chairman/Director/Independent Director
Paul LaViolette
President/Chief Executive Officer/Director
Stavros Vizirgianakis
Chief Financial Officer
Joseph Dwyer
Independent Director
Charles Miner
Chief Operating Officer
Sharon Klugewicz
Senior Vice President/Director of Sales/Director of Marketing
Robert Ludecker
Vice President - Operations
Joseph Brennan
Vice President
John Salerno
Vice President - Research & Development
Daniel Voic
Director
Gwendolyn Watanabe
Independent Director
Patrick McBrayer
Independent Director
Thomas Patton
No Data
About MSON
Misonix, Inc. (Misonix), is a medical devices company. The Company is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company’s products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.

Webull offers kinds of Misonix Inc stock information, including NASDAQ:MSON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MSON stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MSON stock methods without spending real money on the virtual paper trading platform.